{{Rsnum
|rsid=6428503
|Gene=GBP2
|Chromosome=1
|position=89118386
|Orientation=plus
|GMAF=0.3388
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=GBP2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 17.7 | 50.4 | 31.9
| HCB | 17.5 | 48.2 | 34.3
| JPT | 11.5 | 40.7 | 47.8
| YRI | 0.7 | 23.8 | 75.5
| ASW | 3.5 | 31.6 | 64.9
| CHB | 17.5 | 48.2 | 34.3
| CHD | 16.5 | 50.5 | 33.0
| GIH | 24.8 | 54.5 | 20.8
| LWK | 0.0 | 11.8 | 88.2
| MEX | 12.1 | 48.3 | 39.7
| MKK | 3.2 | 35.9 | 60.9
| TSI | 15.7 | 41.2 | 43.1
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs6428503
|Name_s=
|Gene_s=GBP2
|Feature=
|Evidence=PubMed ID:17553421; PubMed ID:19118814
|Annotation=This variant is nominally associated with late-onset Alzheimer disease (LOAD) in 2 GWAS studies.
|Drugs=
|Drug Classes=
|Diseases=Alzheimer Disease
|Curation Level=Curated
|PharmGKB Accession ID=PA162363849
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs6428503
|overall_frequency_n=33
|overall_frequency_d=128
|overall_frequency=0.257812
|n_genomes=22
|n_genomes_annotated=0
|n_haplomes=25
|n_articles=0
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}